Sep 4 |
How Lilly, Novo Could Beat Tesla To The Trillion-Dollar Club; Plus, Nvidia's Battle With Microsoft, Apple
|
Sep 4 |
Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?
|
Sep 4 |
NVS or LLY: Which Is the Better Value Stock Right Now?
|
Sep 4 |
Alzheimer’s Trial Failure Sends Athira Stock Down 75%
|
Sep 4 |
Eli Lilly’s quest for obesity drugs leads to $1B bet on dark genome
|
Sep 4 |
Merck's Keytruda & Padcev Combo Gets EU Nod for Urothelial Carcinoma
|
Sep 4 |
Health Care Roundup: Market Talk
|
Sep 4 |
Zacks Investment Ideas feature highlights: Meta Platforms, Lockheed Martin and Eli Lilly
|
Sep 4 |
Eli Lilly: Zepbound Price Cuts Have Multiple Positives, Limited Downside
|
Sep 4 |
Eli Lilly inks licensing deal to expand Olumiant access in Africa
|